[IEEE 2017 14th International Conference on Service Systems and Service Management (ICSSSM) - Dalian, China (2017.6.16-2017.6.18)] 2017 International Conference on Service Systems and Service Management - The financial and operational performances after horizontal M&A: Empirical analysis
- 作者Jian-Cai Wang, ; Yuan Fu, ; Yuqin Min, ; Bin Zhu,
- 文件大小259.24KB
- 发表时间2017
- DOI10.1109/icsssm.2017.7996251
- 页码1-6
SC alemtuzumab: same benefits as IV alemtuzumab, without infusion reactions2008
Comparing Outcomes Between Alemtuzumab and Non- Alemtuzumab Induction in Kidney Allograft RecipientsOrquiza, M. H.; Moore, J.; Africa, J. B.; Ghasemian, S. R.; Melancon, J. K.; Tucker, M.; Light, J. A. · Transplantation Journal · 2012
Alemtuzumab and Myelodysplasia: A Story of Love and Hate (Possible Alemtuzumab-Induced Myelodysplastic Changes)Braester, A.; Akria, L.; Suriu, C.; Sonkin, V. · Acta Haematologica · 2013
Long-term immunologic effects of alemtuzumab: immune reconstitution and immune function after alemtuzumab therapy for autoimmune diseaseJohn D. Isaacs · 2003
Understanding the positive benefit:risk profile of alemtuzumab in relapsing multiple sclerosis: perspectives from the Alemtuzumab Clinical Development ProgramHavrdova, Eva; Cohen, Jeffrey; Horáková, Dana; Kovarova, Ivana; Meluzinova, Eva · Therapeutics and Clinical Risk Management · 2017
Opportunistic Viral Infections After Alemtuzumab Induction: Results From a Randomized Controlled Trial (RCT) Comparing Alemtuzumab and Basiliximab Induction in Kidney Transplant Recipients (KTRs).Cherukuri, A.; Welberry-Smith, M.; Saundh, B.; Hale, A.; Baker, R. · Transplantation · 2014
Fatal bilateral intracerebral hemorrhage following treatment with alemtuzumab for multiple sclerosis; Tödliche bilaterale intrazerebrale Blutungen nach Therapie mit Alemtuzumab bei Multipler Sklerose;Sinicina, I.; Schlegel, J.; Bise, K.; Liesche, F.; Pankratz, H. · Rechtsmedizin · 2019
Peri-Transplant Alemtuzumab Levels IMPACT ACUTE Gvhd, MIXED Chimerism, and Lymphocyte Recovery Following Reduced Intensity Conditioning with Alemtuzumab, Fludarabine, and MelphalanMarsh, Rebecca A.; Neumeier, Lisa; Mehta, Parinda A.; Jodele, Sonata; Davies, Stella M.; Filipovich, Alexandra · Biology of Blood and Marrow Transplantation · 2016
The EBMT risk scoreGratwohl, A · Bone Marrow Transplantation · 2012
Aldosterone synthase inhibition in humansAzizi, M.; Amar, L.; Menard, J. · Nephrology Dialysis Transplantation · 2013
Physicians Oral AbstractsEBMT 2012Bone Marrow Transplantation · 2012
Causes of death after renal transplantationBriggs, J. D. · Nephrology Dialysis Transplantation · 2001
Abstracts of the Nurses GroupBone Marrow Transplantation · 2009
Author IndexBone Marrow Transplantation · 2010
Minimal Residual DiseaseBone Marrow Transplantation · 1999
Nursing ManagementBone Marrow Transplantation · 1999